Berallo, Jacklyn R.
HRN: 19-94-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/14/2022
09/21/2022
PO
2.3ml On Day 1, Then 1ml Day2-5
OD
Pcap B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes